Zhitong Finance App News, Guanghua Technology (002741.SZ) announced that the company plans to use its own capital of RMB 225 million to transfer part of the shares of Hebei Kainuo Zhongxing Technology Co., Ltd. (hereinafter referred to as “Keno China Star” or “target company”) through capital increase and share transfer. After the transaction is completed, the company will hold 21.46% of Keno Zhongxing's shares (hereinafter referred to as the “target shares”). Keno Zhongxing will become a participating company of the company, and the target company will not be included in the scope of the consolidated company statement.
This investment is an important step for the company to promote industrial collaboration around core circuits such as semiconductor photoresists and pharmaceutical intermediates: Keno Zhongxing is mainly engaged in the development and production of new electronic information materials such as large-scale integrated circuits, photoresist resin monomers for chip manufacturing, photo-producing agents, additives and various supporting reagents, and produces heterocyclic pharmaceutical intermediates such as tetrazole derivatives, triazole derivatives, piperazine, piperidine, and quinoline. It has a strong complementary and collaborative foundation with the company's existing electronic chemicals business in terms of product structure, technical process and target customers. The company can rely on its advantages in fine chemical research and development, production management, quality control, supply chain and customer channels to provide support for industrialization expansion, process optimization and market expansion to accelerate the transformation of its technological achievements into large-scale production capacity; Keno Zhongxing's technology accumulation in the field of key materials in photoresist also helps the company extend to the high value-added links of the semiconductor materials industry chain and jointly enhance the localization support capabilities of key electronic chemicals.